MA51277A - Utilisation d'un extrait végétal en tant qu'agent actif dans des processus de ré-épithélialisation et de cicatrisation de tissus - Google Patents

Utilisation d'un extrait végétal en tant qu'agent actif dans des processus de ré-épithélialisation et de cicatrisation de tissus

Info

Publication number
MA51277A
MA51277A MA051277A MA51277A MA51277A MA 51277 A MA51277 A MA 51277A MA 051277 A MA051277 A MA 051277A MA 51277 A MA51277 A MA 51277A MA 51277 A MA51277 A MA 51277A
Authority
MA
Morocco
Prior art keywords
epithelialization
tissue
active agent
plant extract
healing processes
Prior art date
Application number
MA051277A
Other languages
English (en)
Inventor
Andrea Alimonti
Jessica Cadau
Andrea Maria Giori
Monica Montopoli
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Publication of MA51277A publication Critical patent/MA51277A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA051277A 2017-12-19 2018-12-14 Utilisation d'un extrait végétal en tant qu'agent actif dans des processus de ré-épithélialisation et de cicatrisation de tissus MA51277A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT201700146620 2017-12-19

Publications (1)

Publication Number Publication Date
MA51277A true MA51277A (fr) 2021-03-31

Family

ID=61802257

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051277A MA51277A (fr) 2017-12-19 2018-12-14 Utilisation d'un extrait végétal en tant qu'agent actif dans des processus de ré-épithélialisation et de cicatrisation de tissus

Country Status (12)

Country Link
US (1) US11235016B2 (fr)
EP (1) EP3727414B1 (fr)
CN (1) CN111565735A (fr)
CA (1) CA3084280A1 (fr)
CY (1) CY1125075T1 (fr)
DK (1) DK3727414T3 (fr)
ES (1) ES2909243T3 (fr)
MA (1) MA51277A (fr)
PL (1) PL3727414T3 (fr)
PT (1) PT3727414T (fr)
SM (1) SMT202200144T1 (fr)
WO (1) WO2019121425A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100017678A1 (it) * 2021-07-05 2023-01-05 Altergon Sa Use of a vegetal extract as an active agent in the treatment of a musculoskeletal disorder / uso di un estratto vegetale come agente attivo nel trattamento di patologia muscolo-scheletrica
IT202100017666A1 (it) * 2021-07-05 2023-01-05 Altergon Sa Use of a vegetal extract as an active agent in the treatment of heart diseases / uso di un estratto vegetale come agente attivo nel trattamento di patologie cardiache
CN114480543B (zh) * 2022-01-29 2024-11-05 淮安唯尔美化妆品有限公司 一种植物酶解肽及其抑制瘢痕、制备抑制瘢痕化妆品的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
DE4303823C2 (de) * 1993-02-10 1997-08-07 Isernhagen Heilmittelbetr Gmbh Verwendung eines Extraktes aus Blüten von Salvia officinalis bei der Bekämpfung von Durchblutungsstörungen
CN103845232A (zh) * 2012-12-06 2014-06-11 叶海涛 除皱护理复方浴盐
ITRM20130063A1 (it) * 2013-01-31 2014-08-01 Atrahasis S R L Metodo di screening per identificare sostanze per contrastare l'invecchiamento.

Also Published As

Publication number Publication date
ES2909243T3 (es) 2022-05-06
SMT202200144T1 (it) 2022-05-12
PT3727414T (pt) 2022-03-25
CY1125075T1 (el) 2023-06-09
EP3727414B1 (fr) 2022-01-26
RU2020118154A3 (fr) 2022-04-14
RU2020118154A (ru) 2022-01-20
DK3727414T3 (da) 2022-03-28
CN111565735A (zh) 2020-08-21
PL3727414T3 (pl) 2022-05-09
CA3084280A1 (fr) 2019-06-27
US20200376064A1 (en) 2020-12-03
US11235016B2 (en) 2022-02-01
EP3727414A1 (fr) 2020-10-28
WO2019121425A1 (fr) 2019-06-27

Similar Documents

Publication Publication Date Title
BR112018010234A2 (pt) spray formador de película tópica
BR112018005110A2 (pt) Composição emoliente e sua utilização cosmética, composição cosmética, dermatológica ou farmacêutica e sua utilização cosmética e processo de tratamento cosmético da pele
EP4218823A3 (fr) Nouveaux promédicaments à base d'hormone de croissance humaine (hgh) polymère
MX367091B (es) Una composición farmacéutica o cosmética tópica que comprende un extracto de la baya de la fruta milagrosa (synsepalum dulcificum) para usarse en el tratamiento o la prevención de desórdenes en la piel, mebrana mucosa, cabello, articulaciones y uñas.
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
WO2013186777A3 (fr) Utilisation d'agents bloquants de la signalisation par une protéine morphogénétique osseuse (bmp) pour le traitement de maladies neuroinflammatoires et neurodégénératives
MA51277A (fr) Utilisation d'un extrait végétal en tant qu'agent actif dans des processus de ré-épithélialisation et de cicatrisation de tissus
ZA201801300B (en) Composition and medical device comprising acetylsalicylic acid for the treatment of human papilloma virus skin infections
EP3326637A4 (fr) Utilisation d'un extrait d'écorce de mangoustan dans la préparation d'un médicament visant à traiter des affections cutanées
MX2018000262A (es) Usos terapeuticos de formulaciones de berberina.
MX376473B (es) Composicion para tratar lesiones cerebrales.
EP3302464A4 (fr) Utilisation de cannabinoïdes dans le traitement de l'inflammation et/ou de la douleur oculaire
MX379253B (es) Formulaciones de oximetazolina estabilizadas y sus usos.
MA51278A (fr) Utilisation d'un extrait végétal en tant qu'agent actif dans le traitement de maladies dermatologiques
EP2891496A4 (fr) Composition pharmaceutique contenant un extrait complexe d'aurantii nobilis pericarpium et de crataegus en tant que principe actif, dans le traitement ou la prévention de l'obésité ou de maladies métaboliques d'origine lipidique
MX2018011539A (es) Tratamiento de dolencias y enfermedades cutaneas asociadas a biopeliculas microbianas.
BR112015014261A8 (pt) composto de danazol, seu uso e formulação farmacêutica compreendendo este
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
EP3603656A4 (fr) Composition pharmaceutique pour le traitement prophylactique ou thérapeutique de maladies gynécologiques contenant un extrait de sarcodon imbricatus en tant que principe actif
FR3040625B1 (fr) Principe actif cosmetique issu d'helichrysum stoechas et utilisation pour lutter contre le vieillissement de la peau
ES2672314R1 (es) Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
EP3668526A4 (fr) Compositions de traitement d'infections de membranes de la peau et des muqueuses
EP3338792A4 (fr) Composition de prévention/traitement de lésions de la cornée comportant comme principes actifs de la thymosine bêta 4 et de l'acide citrique
MX2022013816A (es) Composicion farmaceutica para usarse en el aumento del cabello, la modificacion del cuero cabelludo o la piel, la cicatrizacion de una herida, la estimulacion de osteogenesis o la modificacion del cabello.
EP3878457A4 (fr) Agent d'activation des adipocytes bruns/beiges contenant du d-allulose en tant que principe actif